BioInvent: Another Positive BI-1808 Readout - Redeye
Redeye’s conviction in BI-1808 increases with the latest readout in platinum-resistant ovarian cancer. Based on the series of positive readouts since December, we raise our base case.
ANNONS
Redeye’s conviction in BI-1808 increases with the latest readout in platinum-resistant ovarian cancer. Based on the series of positive readouts since December, we raise our base case.
